These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20237460)

  • 1. Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.
    Unschuld PG; Ising M; Roeske D; Erhardt A; Specht M; Kloiber S; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Jun; 35(7):1583-92. PubMed ID: 20237460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder.
    Unschuld PG; Ising M; Erhardt A; Lucae S; Kohli M; Kloiber S; Salyakina D; Thoeringer CK; Kern N; Lieb R; Uhr M; Binder EB; Müller-Myhsok B; Holsboer F; Keck ME
    J Affect Disord; 2008 Jan; 105(1-3):177-84. PubMed ID: 17573119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
    Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
    Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
    J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N; Nothdurfter C; Schüle C; Lieb M; Uhr M; Born C; Zimmermannc R; Bühner M; Konopka K; Rupprecht R; Baghai TC
    J Psychiatr Res; 2014 Jun; 53():76-83. PubMed ID: 24655586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP5 polymorphisms and hypothalamic-pituitary-adrenal axis negative feedback in major depression and obsessive-compulsive disorder.
    Ferrer A; Costas J; Labad J; Salvat-Pujol N; Segalàs C; Urretavizcaya M; Real E; de Arriba-Arnau A; Alonso P; Crespo JM; Barrachina M; Soriano-Mas C; Carracedo Á; Menchón JM; Soria V
    J Psychiatr Res; 2018 Sep; 104():227-234. PubMed ID: 30107269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
    Schuhmacher A; Mössner R; Höfels S; Pfeiffer U; Guttenthaler V; Wagner M; Schwab SG; Maier W; Zobel A
    Int J Neuropsychopharmacol; 2011 Mar; 14(2):237-45. PubMed ID: 20701824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC; Schule C; Zwanzger P; Minov C; Zill P; Ella R; Eser D; Oezer S; Bondy B; Rupprecht R
    Neurosci Lett; 2002 Aug; 328(3):299-303. PubMed ID: 12147330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of the glucocorticoid receptor gene and major depression.
    van Rossum EF; Binder EB; Majer M; Koper JW; Ising M; Modell S; Salyakina D; Lamberts SW; Holsboer F
    Biol Psychiatry; 2006 Apr; 59(8):681-8. PubMed ID: 16580345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.
    Liu Z; Zhu F; Wang G; Xiao Z; Tang J; Liu W; Wang H; Liu H; Wang X; Wu Y; Cao Z; Li W
    Neurosci Lett; 2007 Mar; 414(2):155-8. PubMed ID: 17258395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M; Ida I; Yuuki N; Oshima A; Kumano H; Takahashi K; Fukuda M; Oriuchi N; Endo K; Matsuda H; Mikuni M
    Psychiatry Res; 2007 Aug; 155(3):245-56. PubMed ID: 17587554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.